• Infinity Group exposure provisioned at 100% in 1H FY26
• Estimated recovery from administration: A$11.7m to $15.8m
• Forecasted FY26 revenue: A$3.7b
• Underlying EBITDA forecast: A$95m to A$100m
• Net debt expected: 2 to 2.5 times EBITDA

Paragon Care Limited (ASX:PGC) has provided an update on the receivership of the Infinity Retail Pharmacy Group, revealing a 100% provision against amounts owed by the Infinity Group in its 1H FY26 financial results. The preliminary Estimated Outcome Analysis from the administrators suggests a potential recovery of approximately A$11.7m to $15.8m, representing 24% to 32.5% of the outstanding exposure. The Company has already received a $3.4m recovery from the ATO. Additionally, Paragon Care forecasts revenue of approximately A$3.7b for FY26, with underlying EBITDA expected between A$95m and A$100m, including the acquisition of Haju. Net debt is anticipated to be between 2 to 2.5 times EBITDA, assuming a full-year contribution from acquisitions.

Forecasted FY26 revenue: A$3.7b, Underlying EBITDA: A$95m to A$100m

Paragon Care remains focused on disciplined cost management and working capital optimization, with stable underlying trading performance.